Concepedia

Sandra Robrecht

SR

7

Publications

235

Citations

7

H-Index

2020

Active since

Affiliations

University Hospital Cologne(Current)

University of Cologne

Düsseldorf University Hospital

Heinrich Heine University Düsseldorf

Universität Ulm

Sandra Robrecht is an author at University Hospital Cologne specializing in systems biology, tumor microenvironment, and gene expression.

Top concepts

Publications per year

2020–2024

7

Publications

7

Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study

Othman Al‐Sawaf, Sandra Robrecht, Can Zhang et al. · Blood · 2024 · 92 citations · Full text

First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

Moritz Fürstenau, Arnon P. Kater, Sandra Robrecht et al. · The Lancet Oncology · 2024 · 59 citations · Full text

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

Moritz Fürstenau, Yvonne J. Thus, Sandra Robrecht et al. · Blood · 2023 · 35 citations · Full text

Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicentre, open-label phase-II trial

Paula Cramer, Julia von Tresckow, Sandra Robrecht et al. · Haematologica · 2020 · 15 citations · Full text

The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL

Johanna Stachelscheid, Qu Jiang, Christoph Markus Aszyk et al. · Blood · 2022 · 12 citations · Full text

, , +12

Rows per page

1–5 of 7